NM/CT 870 CZT
SPECT/CT as you have never seen it before
NM/CT 870 CZT is the third-generation of our general purpose digital SPECT/CT system powered by CZT technology. An important capability of NM/CT 870 CZT is the ability to image low energy and medium energy isotopes with energies up to 250 keV. Accessibility to the Medium Energy High Resolution & Sensitivity (MEHRS) collimator, via collimator exchange, will expand your SPECT/CT offering to include Theranostics applications.
FEATURES
A SPECT/CT system for true discovery
The latest generation offers the SmartConsole, CT features, and the capability of imaging the higher energy peaks of medium energy isotopes. Help bring your theories to life with a system designed to leverage all that CZT can do for a wide variety of procedures.
DESIGN
Designed for patient comfort and increased versatility
PRODUCTIVITY
Switch to an all-digital workflow
BUILT FOR QUANTITATION
Quantitative SPECT/CT for every patient, every day
PRODUCTIVITY
One home for all your molecular images
See everything clearly now
As molecular imaging continues to move toward the development of disease-specific diagnoses and increasingly personalized care, resolution is important. Early disease detection is only possible with a high system resolution that enables visualization of finer anatomic detail.
The resolution to discover something new
DISCLAIMERS
1. In clinical practice, the use of NM/CT 870 CZT with WEHR collimator may improve lesion detectability depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose or scan time to obtain diagnostic image quality for the particular clinical task.
2. Together with WEHR collimator, Clarity 2D and Evolution3 and compared to Discovery NM/CT 670 Pro/ES/DR without Clarity 2D and Evolution3. As demonstrated in phantom testing using a bone scan protocol, and the NEMA IEC Body Phantom. The actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice.
3. In clinical practice, Evolution options3a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit3b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.
3a. Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.
3b. Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.
4. NM/CT 870 CZT using WEHR and Clarity 2D. As compared to Discovery NM/CT 670 Pro / ES / DR.
5. NM/CT 870 CZT using WEHR. As demonstrated in NEMA IEC Body Phantom. As compared to Discovery NM/CT 670 Pro / ES / DR.
6. At detector surface.
7. As compared to Discovery NM/CT 670 Pro / ES / DR.
8. Demonstrated in phantom testing using NEMA IEC Body Phantom at 50% scan times with WEHR collimator and Evolution3. Compared to Discovery NM/CT 670 Pro/ES/DR.
2. Together with WEHR collimator, Clarity 2D and Evolution3 and compared to Discovery NM/CT 670 Pro/ES/DR without Clarity 2D and Evolution3. As demonstrated in phantom testing using a bone scan protocol, and the NEMA IEC Body Phantom. The actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice.
3. In clinical practice, Evolution options3a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit3b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.
3a. Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.
3b. Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.
4. NM/CT 870 CZT using WEHR and Clarity 2D. As compared to Discovery NM/CT 670 Pro / ES / DR.
5. NM/CT 870 CZT using WEHR. As demonstrated in NEMA IEC Body Phantom. As compared to Discovery NM/CT 670 Pro / ES / DR.
6. At detector surface.
7. As compared to Discovery NM/CT 670 Pro / ES / DR.
8. Demonstrated in phantom testing using NEMA IEC Body Phantom at 50% scan times with WEHR collimator and Evolution3. Compared to Discovery NM/CT 670 Pro/ES/DR.